Skip to content

Pulmonary Diffusing Capacity During Postural Postural Changes and Acute Exercise

Pulmonary Diffusing Capacity Changes to Posture and Acute Exercise in Healthy Volunteers: a Randomised Test-retest Relaibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04963504
Acronym
DiffLung
Enrollment
20
Registered
2021-07-15
Start date
2021-07-12
Completion date
2021-10-30
Last updated
2021-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Assessments of Pulmonary Diffusing Capacity

Brief summary

The combined measurement of the pulmonary diffusing capacity to carbon monoxide (CO) and nitric oxide (NO) (DLCO/NO) has recently been standardised and validated for clinical use. It involves a very short breath-hold time (≤5 seconds), and it may be repeated up to 12 times without affecting measurements, and it is thus ideal for assessing acute changes in pulmonary diffusing capacity and its components during various physiological manoeuvres. The aim of the present study is to compare the test-retest reliability of pulmonary diffusing capacity measurements during postural changes (sitting vs. supine) vs. rest-to-exercise. DLCO/NO will either be measured in the sitting position during rest vs. exercise or in the sitting and supine posture, and this will be repeated within 1-7 days in 20 healthy individuals that will be randomised to one of the two interventions. Statistically,the test-retest relaibility of sitting-to-supine vs. rest-to-exercise changes in DLCO/NO will be compared by parametric methods.

Interventions

DIAGNOSTIC_TESTRest-to-exercise

Pulmonary diffusing capacity is assessed at rest and during exercise (70% of VO2max on a bicycle ergometer)

DIAGNOSTIC_TESTSitting-to-supine

Pulmonary diffusing capacity is assessed in the sitting and supine position

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Randomised study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

• Regular exercise (1-3 timer per week)

Exclusion criteria

* Any known medical condition that requires regular medication or any known lung condition * Smoking * Symptoms of disease within 2 weeks prior to the study * Abnormal lung function test * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Between intervention DLNO/DLCO-ratio repeatability coefficient1 weekTest-retest reliability coefficient of rest-to-exercise and supine-to-prone DLNO/DLCO-ratio
Between intervention DLCO repeatability coefficient1 weekTest-retest repeatability coefficient of rest-to-exercise and supine-to-prone DLCO
Between intervention DLNO repeatability coefficient1 weekTest-retest repeatability coefficient of rest-to-exercise and supine-to-prone DLNO

Secondary

MeasureTime frameDescription
Between intervention DM repeatability coefficient1 weekTest-retest repeatability coefficient of rest-to-exercise and supine-to-prone DM
Between intervention Vc repeatability coefficient1 weekTest-retest repeatability coefficient of rest-to-exercise and supine-to-prone Vc

Other

MeasureTime frameDescription
DM SEM1 weekBetween-day SEM of DM from rest-to-exercise and supine-to-prone
Vc SEM1 weekBetween-day SEM of Vc from rest-to-exercise and supine-to-prone
DLNO/DLCO-ratio CV1 weekBetween-day CV of DLNO/DLCO from rest-to-exercise and supine-to-prone
DLCO CV1 weekBetween-day CV of DLCO from rest-to-exercise and supine-to-prone
DLNO CV1 weekBetween-day CV of DLNO from rest-to-exercise and supine-to-prone
DM CV1 weekBetween-day CV of DM from rest-to-exercise and supine-to-prone
Vc CV1 weekBetween-day CV of Vc from rest-to-exercise and supine-to-prone
DM MDC1 weekBetween-day MDC of DM from rest-to-exercise and supine-to-prone
Vc MDC1 weekBetween-day Vc of DM from rest-to-exercise and supine-to-prone
DLNO/DLCO-ratio ICC1 weekBetween-day ICC of DLNO/DLCO from rest-to-exercise and supine-to-prone
DM ICC1 weekBetween-day ICC of DM from rest-to-exercise and supine-to-prone
DLNO ICC1 weekBetween-day ICC of DLNO from rest-to-exercise and supine-to-prone
Between day DLNO/DLCO-ratio repeatability coefficient1 weekBetween-day repeatability coefficient of DLNO/DLCO at rest in both groups combined
Between day DLCO repeatability coefficient1 weekBetween-day repeatability coefficient of DLCO at rest in both groups combined
Between day DLNO repeatability coefficient1 weekBetween-day repeatability coefficient of DLNO at rest in both groups combined
Between day DM repeatability coefficient1 weekBetween-day repeatability coefficient of DM at rest in both groups combined
Between day Vc repeatability coefficient1 weekBetween-day repeatability coefficient of Vc at rest in both groups combined
DLNO/DLCO-ratio MDC1 weekBetween-day MDC of DLNO/DLCO from rest-to-exercise and supine-to-prone
DLCO MDC1 weekBetween-day MDC of DLCO from rest-to-exercise and supine-to-prone
DLNO MDC1 weekBetween-day MDC of DLNO from rest-to-exercise and supine-to-prone
DLCO ICC1 weekBetween-day ICC of DLCO from rest-to-exercise and supine-to-prone
Vc ICC1 weekBetween-day ICC of Vc from rest-to-exercise and supine-to-prone
DLNO/DLCO-ratio SEM1 weekBetween-day SEM of DLNO/DLCO from rest-to-exercise and supine-to-prone
DLCO SEM1 weekBetween-day SEM of DLCO from rest-to-exercise and supine-to-prone
DLNO SEM1 weekBetween-day SEM of DLNO from rest-to-exercise and supine-to-prone

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026